Second person cured of HIV after experimental stem cell transplant

adam p
Adam Castillejo, known in the scientific literature as the London Patient. Credit: Andrew Testa/The New York Times

A London man living with HIV who received an experimental stem cell transplant has appeared free of the virus for at least 30 months despite no longer taking medication. They say it’s strong evidence that he may be cured of HIV—the second such case ever documented.

Nearly four years ago, the man known as the London patient received a bone marrow transplant primarily meant to help treat his advanced blood cancer, Hodgkin’s lymphoma. But the transplant was sourced from a donor with a rare mutation that makes people nearly impervious to the most common type of HIV infection, HIV-1. Doctors hoped the transplant would not only help treat the man’s cancer but also reboot his immune system to resemble the donor’s, transferring that same resistance to HIV.

…

[T]here are many practical reasons why we can’t just give everyone living with HIV these kinds of stem cell transplants (for one, they’re a very risky, last-resort procedure). We also don’t necessarily need a cure to end HIV as a public health threat, as I reported recently in an article about ending HIV. But researchers hope to build on the lessons learned from [London patient Adam] Castillejo and [Berlin patient Timothy Ray] Brown to someday cure HIV for good.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot-2026-10-11-at-10.24.21-AM
Viewpoint: RFK Jr.’s new CDC head Erica Schwartz greenlights hepatitis B vaccine study critics call “unethical and designed to cast doubts on its safety”
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot 2026-10-12 at 12.25
Tearful onions? CRISPR has a solution for that
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
Concerned-Farmer-at-Golden-Hour
GAHA: The corporate-created “healthier America” movement challenging what it claims is MAHA misinformation about modern farming, chemicals, and food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.